These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32149549)

  • 1. Characterization of deficit schizophrenia and reliability of the bidimensional model of its negative symptomatology.
    López-Díaz Á; Menéndez-Sampil C; Pérez-Romero A; Palermo-Zeballos FJ; Valdés-Florido MJ
    Nord J Psychiatry; 2020 Aug; 74(6):400-406. PubMed ID: 32149549
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurocognitive Impairments in Deficit and Non-Deficit Schizophrenia and Their Relationships with Symptom Dimensions and Other Clinical Variables.
    Yu M; Tang X; Wang X; Zhang X; Zhang X; Sha W; Yao S; Shu N; Zhang X; Zhang Z
    PLoS One; 2015; 10(9):e0138357. PubMed ID: 26381645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome.
    Galderisi S; Bucci P; Mucci A; Kirkpatrick B; Pini S; Rossi A; Vita A; Maj M
    Schizophr Res; 2013 Jun; 147(1):157-162. PubMed ID: 23608244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study.
    Albayrak Y; Ünsal C; Beyazyüz M; Ünal A; Kuloğlu M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():144-9. PubMed ID: 23657077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eye movement characteristics in male patients with deficit and non-deficit schizophrenia and their relationships with psychiatric symptoms and cognitive function.
    Zhang L; Zhang X; Fang X; Zhou C; Wen L; Pan X; Zhang F; Chen J
    BMC Neurosci; 2021 Nov; 22(1):70. PubMed ID: 34819034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of premorbid functioning during childhood in patients with deficit vs. non-deficit schizophrenia and in their healthy siblings.
    Bucci P; Mucci A; Piegari G; Nobile M; Pini S; Rossi A; Vita A; Galderisi S; Maj M
    Schizophr Res; 2016 Jul; 174(1-3):172-176. PubMed ID: 26825584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia.
    Galderisi S; Quarantelli M; Volpe U; Mucci A; Cassano GB; Invernizzi G; Rossi A; Vita A; Pini S; Cassano P; Daneluzzo E; De Peri L; Stratta P; Brunetti A; Maj M
    Schizophr Bull; 2008 Mar; 34(2):393-401. PubMed ID: 17728266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deficit syndrome of the psychotic illness. A clinical and nosological study.
    Peralta V; Cuesta MJ
    Eur Arch Psychiatry Clin Neurosci; 2004 Jun; 254(3):165-71. PubMed ID: 15205970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction.
    Tang X; Zhou C; Gao J; Duan W; Yu M; Xiao W; Zhang X; Dong H; Wang X; Zhang X
    BMC Psychiatry; 2019 Aug; 19(1):254. PubMed ID: 31420036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF rs 6265 polymorphism and COMT rs 4680 polymorphism in deficit schizophrenia in Polish sample.
    Pełka-Wysiecka J; Wroński M; Jasiewicz A; Grzywacz A; Tybura P; Kucharska-Mazur J; Bieńkowski P; Samochowiec J
    Pharmacol Rep; 2013; 65(5):1185-93. PubMed ID: 24399714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study.
    Arango C; Bobes J; Kirkpatrick B; Garcia-Garcia M; Rejas J
    Eur Neuropsychopharmacol; 2011 Dec; 21(12):867-75. PubMed ID: 21477998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The factorial structure of the schedule for the deficit syndrome in schizophrenia.
    Kimhy D; Yale S; Goetz RR; McFarr LM; Malaspina D
    Schizophr Bull; 2006 Apr; 32(2):274-8. PubMed ID: 16177274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P50 gating in deficit and nondeficit schizophrenia.
    Santos JL; Sánchez-Morla EM; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
    Schizophr Res; 2010 Jun; 119(1-3):183-90. PubMed ID: 20153607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation and gene expression of the chemokine (C-X-C motif) ligand 1 in patients with deficit and non-deficit schizophrenia.
    Zhou C; Chen J; Tang X; Feng X; Yu M; Sha W; Wang X; Zhang X; Yi H; Zhang X
    Psychiatry Res; 2018 Oct; 268():82-86. PubMed ID: 30015110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of the diagnosis of deficit syndrome in schizophrenia.
    Amador XF; Kirkpatrick B; Buchanan RW; Carpenter WT; Marcinko L; Yale SA
    Am J Psychiatry; 1999 Apr; 156(4):637-9. PubMed ID: 10200748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergent and divergent altered patterns of default mode network in deficit and non-deficit schizophrenia.
    Zhou C; Yu M; Tang X; Wang X; Zhang X; Zhang X; Chen J
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():427-434. PubMed ID: 30367960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gray matter changes in patients with deficit schizophrenia and non-deficit schizophrenia.
    Özdemir Hİ; Eker MÇ; Zengin B; Yılmaz DA; İşman Haznedaroğlu D; Çınar C; Kitiş Ö; Akay A; Gönül AS
    Turk Psikiyatri Derg; 2012; 23(4):237-46. PubMed ID: 23225124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia.
    Lei W; Deng W; Li M; He Z; Han Y; Huang C; Ma X; Wang Q; Guo W; Li Y; Jiang L; Gong Q; Hu X; Zhang N; Li T
    Psychiatry Res; 2015 Nov; 234(2):219-226. PubMed ID: 26409573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in inflammatory marker profiles and cognitive functioning between deficit and nondeficit schizophrenia.
    Wang D; Wang Y; Chen Y; Yu L; Wu Z; Liu R; Ren J; Fang X; Zhang C
    Front Immunol; 2022; 13():958972. PubMed ID: 36341400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotaxy-based regional brain volumetry applied to segmented MRI: validation and results in deficit and nondeficit schizophrenia.
    Quarantelli M; Larobina M; Volpe U; Amati G; Tedeschi E; Ciarmiello A; Brunetti A; Galderisi S; Alfano B
    Neuroimage; 2002 Sep; 17(1):373-84. PubMed ID: 12482090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.